Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gengnianningxin granules
- Development stage
- Unknown
- Lead developer
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Gengnianningxin granules is a traditional Chinese medicine (TCM) herbal formulation developed for the treatment of perimenopausal syndrome (climacteric syndrome). It is used to alleviate symptoms associated with menopause, such as hot flashes, insomnia, nervousness, and emotional fluctuations, by addressing underlying TCM patterns like Kidney-Yin deficiency. Clinical evaluation, including a randomized, double-blind, placebo-controlled trial sponsored by Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, has investigated its efficacy and safety in women experiencing perimenopausal symptoms.
- Other names
- Gengnianningxin GranulesGengnianningxin Keli更年宁心颗粒
Beyond the preview
Go deeper on Gengnianningxin granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gengnianningxin granules.